Trends in anticoagulation in Australia

For various reasons, people with Alzheimer’s disease are less likely to be treated with oral anticoagulants. A team based in Australia and Finland has recently explored the incidence and prevalence of warfarin and direct oral anticoagulant (DOAC) amongst a large...

How does polypharmacy cause falls?

Polypharmacy has long been thought to be linked to increased incidence of falls. A recent Canadian cohort study assessing community‐dwelling older adults included 5 years of follow‐up to assess this issue amongst people aged 65 years and older (n = 249; 76.6 ± 8.6 y;...

Long-term side effects of PPIs assessed in large RCT

Discussion about the long term side effects of Proton pump inhibitors (PPIs) continues, but almost all meaningful data to date have been derived from pharmacoepidemiological studies based upon naturalistic observational techniques. A large randomized trial has now...

Medical cannabis – impact on opioid use in pain

Medical Cannabis may impact opioid and benzodiazepine requirements for pain control, according to recent research from the USA. A single-center, retrospective cohort study evaluated opioid and benzodiazepine doses over a 6-month time period for patients using medical...